Why Aflac (AFL) is on investors’ radar right now

Aflac (AFL) is drawing fresh attention after first quarter 2026 results came in below analyst expectations for revenue and profit, even as management pointed to product driven momentum in Japan.

The stock has been relatively steady around US$114.46, with a 30 day share price return of 3.6% and a 1 year total shareholder return of 10.4%. The 3 and 5 year total shareholder returns of 81.3% and 132.4% point to longer term compounding, even as recent earnings, the ongoing share buyback and the new Maine office shape expectations.

If Aflac's mix of steady returns and business updates has you thinking about what else is out there, this could be a good moment to scan 19 top founder-led companies

With Aflac trading around US$114.46, sitting slightly above analyst price targets but showing a meaningful intrinsic discount, investors now face a key question: is there still upside here or is the market already pricing in future growth?

Most Popular Narrative: 2% Overvalued

Aflac's most followed narrative pegs fair value at $111.86, slightly below the last close of $114.46. This frames the current debate around modest overvaluation.

The analysts have a consensus price target of $111.86 for Aflac based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $126.0, and the most bearish reporting a price target of just $97.0.

The narrative leans on flat revenue assumptions, shrinking margins, and a richer future earnings multiple, all pulled together with a single discount rate. It is worth considering which of these levers has the largest impact in that $111.86 fair value estimate.

Result: Fair Value of $111.86 (OVERVALUED)

However, the picture could change if Japan premiums keep declining or U.S. sales stay muted. This would pressure revenue, margins and the current earnings narrative.

Another Angle on Valuation

Analysts see Aflac as about 2% overvalued at $114.46 versus their $111.86 target, but the current 12.6x P/E tells a different story. It sits below peer averages at 14.1x, yet above a 9.7x fair ratio, which hints at both downside risk and possible re rating room. Where do you think the multiple drifts next?

Next Steps

With the story feeling finely balanced between caution and optimism, it pays to move quickly, review the numbers for yourself, and weigh the 2 key rewards and 2 important warning signs

Looking for more investment ideas?

If you stop with just one stock, you risk missing opportunities that fit your goals even better, so keep widening the net and pressure testing your ideas.

• Target potential bargains with strong fundamentals by scanning 51 high quality undervalued stocks that combine quality with attractive pricing.
• Lock in income focused opportunities by reviewing 13 dividend fortresses built around higher yielding, resilient payers.
• Prioritise stability by checking 72 resilient stocks with low risk scores that aim to keep overall portfolio risk in check.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.